P

Inventor

SAUNDERS JEFFREY O

US64 patents
⚠️ This page may combine multiple inventors who share the name “SAUNDERS JEFFREY O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERTEX PHARMA

20 patents
US6344465B1Feb 5, 2002

Inhibitors of IMPDH enzyme

VERTEX PHARMA186 citations99
US6054472AApr 25, 2000

Inhibitors of IMPDH enzyme

VERTEX PHARMA242 citations99
US5807876ASep 15, 1998

Inhibitors of IMPDH enzyme

VERTEX PHARMA304 citations99
US5516797AMay 14, 1996

Immunosuppressive compounds

VERTEX PHARMA121 citations99
US5330993AJul 19, 1994

Immunosuppressive compounds

VERTEX PHARMA143 citations99
US6541496B1Apr 1, 2003

Inhibitors of IMPDH enzyme

VERTEX PHARMA80 citations98
US5192773AMar 9, 1993

Immunosuppressive compounds

VERTEX PHARMA163 citations97
US5717092AFeb 10, 1998

Compounds with improved multi-drug resistance activity

VERTEX PHARMA54 citations96
US5620971AApr 15, 1997

Biologically active acylated amino acid derivatives

VERTEX PHARMA88 citations96
US6653309B1Nov 25, 2003

Inhibitors of IMPDH enzyme technical field of the invention

VERTEX PHARMA131 citations95
US5622970AApr 22, 1997

Immunosuppressive compounds

VERTEX PHARMA61 citations95
US5723459AMar 3, 1998

Biologically active acylated amino acid derivatives

VERTEX PHARMA28 citations92
US5932600AAug 3, 1999

Inhibitors of IMPDH enzyme

VERTEX PHARMA22 citations91
US7989498B2Aug 2, 2011

Inhibitors of IMPDH enzyme

VERTEX PHARMA19 citations90
US6518291B1Feb 11, 2003

Inhibitors of IMPDH enzyme

VERTEX PHARMA30 citations90
US6967214B2Nov 22, 2005

Inhibitors of IMPDH enzyme

VERTEX PHARMA12 citations84
US7432290B2Oct 7, 2008

Inhibitors of IMPDH enzyme

VERTEX PHARMA6 citations74
US7329681B2Feb 12, 2008

Inhibitors of IMPDH enzyme

VERTEX PHARMA8 citations74
US5935954AAug 10, 1999

Compounds with improved multi-drug resistance activity

VERTEX PHARMA9 citations74
US7485664B2Feb 3, 2009

Inhibitors of TACE

VERTEX PHARMA2 citations61

AGIOS PHARMACEUTICALS INC

15 patents
US9512107B2Dec 6, 2016

Therapeutically active compositions and their methods of use

AGIOS PHARMACEUTICALS INC25 citations94
US9732062B2Aug 15, 2017

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC16 citations92
US10294215B2May 21, 2019

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC6 citations84
US10029987B2Jul 24, 2018

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC9 citations84
US9458132B2Oct 4, 2016

Therapeutic compounds and compositions and their use as PKM2 modulators

AGIOS PHARMACEUTICALS INC18 citations84
US10610125B2Apr 7, 2020

Methods and compositions for cell-proliferation-related disorders

AGIOS PHARMACEUTICALS INC9 citations81
US11505538B1Nov 22, 2022

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC1 citations73
US9657004B2May 23, 2017

Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use

AGIOS PHARMACEUTICALS INC1 citations63
US12428376B2Sep 30, 2025

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC0 citations62
US11866411B2Jan 9, 2024

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC0 citations62
USRE49582EJul 18, 2023

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC0 citations62
US10988448B2Apr 27, 2021

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC0 citations62
US10202339B2Feb 12, 2019

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC1 citations62
US10011574B2Jul 3, 2018

Glutaminase inhibitors and method of use

AGIOS PHARMACEUTICALS INC1 citations62

SALITURO FRANCESCO G

6 patents

SQUIBB & SONS INC

5 patents

LEMIEUX RENE M

2 patents

(unassigned)

1 patent

ELIXIR PHARMACEUTICALS INC

1 patent

Showing the top 50 of 64 patents by PatentIndex Score.